Press release out today from the offices of Thought Leader Select.
FOR IMMEDIATE RELEASE
(CHAPEL HILL, NC)—Thought Leader Select, a North Carolina firm dedicated to delivering objective, validated research on medical experts, announces the commencement of a payer key opinion leader project for a top global pharmaceutical company.
The client has engaged Thought Leader Select to identify medical experts specializing in reimbursement and regulatory activities for new medicines to treat metabolic disorders. For the assessment, Thought Leader Select will utilize its deep-profiling research methodology and deliver its findings through its proprietary, web-based global expert tool. This assessment will help the client gain a better understanding of how these thought leaders can assist in navigating the complicated healthcare reimbursement system.
Thought leaders can specialize in several different areas, and the subjects of the coming assessment will have particular experience in reimbursement-related issues.
“I’m very excited for us to be doing this payer KOL project in Canada,” stated Neil Mellor, Thought Leader Select’s principal agent for business development in North America, from his office near Toronto. “While we have worked in over 15 therapeutic areas and 35 disease states, we have established ourselves as the go-to company for research on experts in metabolic disorders.”
About Thought Leader Select
Thought Leader Select is a specialty firm focused on providing solutions—research, technology tools and focused advice/consulting—for more effective KOL engagement and deployment in the healthcare industry. Thought Leader Select’s groundbreaking work bridges the areas of research, communications and technology. With more than 100 years of combined experience working in and with the pharmaceutical industry, Thought Leader Select is addressing needs for better engagement and more sophisticated deployment of KOLs during drug development and the life cycle of the brand.
Director of Global Marketing and Client Relations